Search filters

List of works by Gavin Giovannoni

"No evident disease activity": The use of combined assessments in the management of patients with multiple sclerosis

scientific article published on April 2017

A Risk Score for Predicting Multiple Sclerosis

scientific article

A dystonic syndrome associated with anti-basal ganglia antibodies

scientific article

A phase II baseline versus treatment study to determine the efficacy of raltegravir (Isentress) in preventing progression of relapsing remitting multiple sclerosis as determined by gadolinium-enhanced MRI: The INSPIRE study

article published in 2018

A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis

scientific article

A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis

scientific article (publication date: 2 March 2006)

A service development study of the assessment and management of fracture risk in Parkinson's disease

scientific article

A specific ELISA for measuring neurofilament heavy chain phosphoforms

scientific article

ALEMTUZUMAB IMPROVES 3-YEAR QUALITY OF LIFE IN CARE-MS II

scientific article published on 14 October 2015

Achieving patient engagement in multiple sclerosis: A perspective from the multiple sclerosis in the 21st Century Steering Group

scientific article published on 02 March 2015

Acute axonal damage predicts clinical outcome in patients with multiple sclerosis

scientific article

Adaptation of the nitrate reductase and Griess reaction methods for the measurement of serum nitrate plus nitrite levels

scientific article published in March 1997

Age-associated hyper-methylated regions in the human brain overlap with bivalent chromatin domains

scientific article

Alemtuzumab CARE-MS I 5-year follow-up: Durable efficacy in the absence of continuous MS therapy

scientific article

Alemtuzumab CARE-MS II 5-year follow-up: Efficacy and safety findings

scientific article

Alemtuzumab improves preexisting disability in active relapsing-remitting MS patients

scientific article published on 12 October 2016

Alemtuzumab improves quality-of-life outcomes compared with subcutaneous interferon beta-1a in patients with active relapsing-remitting multiple sclerosis

scientific article published on 24 November 2016

Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial

scientific article (publication date: November 2012)

An ELISA for glial fibrillary acidic protein

scientific article published on April 2004

An Updated Meta-Analysis of Risk of Multiple Sclerosis following Infectious Mononucleosis ⬇️

scientific article published on September 1, 2010

An experimental model of secondary progressive multiple sclerosis that shows regional variation in gliosis, remyelination, axonal and neuronal loss

scientific article published on 30 July 2008

Anti-basal ganglia antibodies: a possible diagnostic utility in idiopathic movement disorders?

scientific article

Antibasal ganglia antibodies and their relevance to movement disorders

scientific article published in August 2004

Antineuronal antibody status and phenotype analysis in Tourette's syndrome

scientific article

Are antibasal ganglia antibodies important, and clinically useful?

scientific article

Assay selection affects John Cunningham virus serostatus classification in multiple sclerosis

scientific article published in August 2012

Assessing interactions between HLA-DRB1*15 and infectious mononucleosis on the risk of multiple sclerosis ⬇️

scientific article published on February 14, 2013

Assessing treatment response to interferon-β: is there a role for MRI?

scientific article published on 11 December 2013

Atraumatic needles for lumbar puncture: why haven't neurologists changed?

scientific article published on 08 September 2015

Autoimmune disease in people with multiple sclerosis and their relatives: a systematic review and meta-analysis ⬇️

scientific article published on January 12, 2013

Bacterial vaccines for the treatment of multiple sclerosis and other autoimmune disorders

scientific article

Biomarker report from the phase II lamotrigine trial in secondary progressive MS - neurofilament as a surrogate of disease progression

scientific article

Biomarker research in multiple sclerosis: addressing axonal damage and heterogeneity

scientific article published on June 2007

Bone health and multiple sclerosis ⬇️

scientific article published on June 27, 2012

Bone health in chronic neurological diseases: a focus on multiple sclerosis and parkinsonian syndromes ⬇️

scientific article published on April 1, 2013

Bradykinesia akinesia inco-ordination test (BRAIN TEST): an objective computerised assessment of upper limb motor function

scientific article

Brain health: time matters in multiple sclerosis

scientific article

Cannabinoid-mediated neuroprotection, not immunosuppression, may be more relevant to multiple sclerosis

scientific article published on 26 November 2007

Cannabinoids inhibit neurodegeneration in models of multiple sclerosis

scientific article published on 22 July 2003

Cerebrospinal fluid and urinary biomarkers in multiple sclerosis ⬇️

scientific article published on March 7, 2013

Cerebrospinal fluid biomarkers in multiple sclerosis

scientific article published on 05 May 2009

Cerebrospinal fluid nitrite/nitrate correlated with oxyhemoglobin and outcome in patients with subarachnoid hemorrhage

scientific article published on April 2004

Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: a meta-analysis of prevalence, prognosis and effect of latitude ⬇️

scientific article published on February 21, 2013

Cerebrospinal fluid tau concentrations in HIV infected patients with suspected neurological disease

scientific article published on December 2000

Change practice now! Using atraumatic needles to prevent post lumbar puncture headache

scientific article

Chlamydophila pneumoniae infection of the central nervous system in patients with multiple sclerosis.

scientific article published on January 2004

Circulating lymphocyte levels and relationship with infection status in patients with relapsing-remitting multiple sclerosis treated with daclizumab beta

scientific article published on September 2017

Cladribine tablets for relapsing-remitting multiple sclerosis: Efficacy across patient subgroups from the phase III CLARITY study

scientific article

Cladribine to Treat Relapsing Forms of Multiple Sclerosis

scientific article published on 22 November 2017

Cladribine to treat disease exacerbation after fingolimod discontinuation in progressive multiple sclerosis

scientific article published on 17 May 2017

Clinical Significance of Gastrointestinal and Flushing Events in Patients with Multiple Sclerosis Treated with Delayed-Release Dimethyl Fumarate

scientific article

Clinical efficacy of BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: subgroup analyses of the DEFINE study

scientific article published in September 2013

Comparative utility of disability progression measures in PPMS: Analysis of the PROMiSe data set.

scientific article

Comparison of two commercial ELISA systems for evaluating anti‐EBNA1 IgG titers ⬇️

scientific article published on January 1, 2013

Complexity of MS management in the current treatment era.

scientific article published in April 2018

Consensus Guidelines for CSF and Blood Biobanking for CNS Biomarker Studies

scientific article

Consistent efficacy of daclizumab beta across patient demographic and disease activity subgroups in patients with relapsing-remitting multiple sclerosis

scientific article published on 19 June 2017

Contribution of Relapse-Independent Progression vs Relapse-Associated Worsening to Overall Confirmed Disability Accumulation in Typical Relapsing Multiple Sclerosis in a Pooled Analysis of 2 Randomized Clinical Trials

scientific article published on 08 June 2020

Control of spasticity in a multiple sclerosis model using central nervous system-excluded CB1 cannabinoid receptor agonists

scientific article published on 11 October 2013

Correction: Meta-Analysis of the Relationship between Multiple Sclerosis and Migraine.

scientific article published in April 2013

Correlating immunological and magnetic resonance imaging markers of disease activity in multiple sclerosis

scientific article published on May 1, 1998

Cost-effectiveness analyses of natalizumab (Tysabri) compared with other disease-modifying therapies for people with highly active relapsing-remitting multiple sclerosis in the UK.

scientific article published on January 2008

Cytokine profiles show heterogeneity of interferon-β response in multiple sclerosis patients

scientific article published on 27 January 2016

Cytomegalovirus and multiple sclerosis risk ⬇️

scientific article published on April 16, 2013

DACLIZUMAB HYP IN MULTIPLE SCLEROSIS: 3-YEAR RESULTS FROM SELECTED

scientific article published on 15 November 2016

DACLIZUMAB HYP VS IM INTERFERON BETA-1A IN MS: NEDA RESULTS FROM DECIDE

scientific article published on 15 November 2016

Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECT): a randomised, double-blind, placebo-controlled trial ⬇️

scientific article published on April 4, 2013

Decreased level of kynurenic acid in cerebrospinal fluid of relapsing-onset multiple sclerosis patients

scientific article published in October 2002

Delayed-release dimethyl fumarate and disability assessed by the Multiple Sclerosis Functional Composite: Integrated analysis of DEFINE and CONFIRM.

scientific article

Depletion of CD52-positive cells inhibits the development of central nervous system autoimmune disease, but deletes an immune-tolerance promoting CD8 T-cell population. Implications for secondary autoimmunity of alemtuzumab in multiple sclerosis

scientific article published on 07 December 2016

Detection of 14-3-3 brain protein in cerebrospinal fluid of HIV infected patients

scientific article published in October 2000

Developing Biomarkers for MS.

scientific article

Development of protein biomarkers in cerebrospinal fluid for secondary progressive multiple sclerosis using selected reaction monitoring mass spectrometry (SRM-MS) ⬇️

scientific article published on July 30, 2012

Disease Modifying Drugs in Multiple Sclerosis: Mechanisms of Action and New Drugs in the Horizon ⬇️

scientific article published on August 1, 2012

Disease activity in progressive multiple sclerosis can be effectively reduced by cladribine

scientific article published on 01 June 2018

Disease-activity-free status in patients with relapsing-remitting multiple sclerosis treated with daclizumab high-yield process in the SELECT study

scientific article published on 10 September 2013

Dopamine reuptake transporter-single-photon emission computed tomography and transcranial sonography as imaging markers of prediagnostic Parkinson's disease

scientific article published on 30 January 2018

Dyskinesias and associated psychiatric disorders following streptococcal infections

scientific article

EFNS guidelines on disease-specific CSF investigations

scientific article

Editors' Welcome

scientific article

Editors' Welcome: Pregnancy and progressive multifocal leukoencephalopathy

scientific article published on 01 April 2018

Effect of cladribine tablets on lymphocyte reduction and repopulation dynamics in patients with relapsing multiple sclerosis

scientific article published on 24 January 2019

Effect of daclizumab high-yield process in patients with highly active relapsing-remitting multiple sclerosis

scientific article published on 29 December 2013

Effect of delayed-release dimethyl fumarate on no evidence of disease activity in relapsing-remitting multiple sclerosis: integrated analysis of the phase III DEFINE and CONFIRM studies

scientific article

Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study

scientific article

Effect of plasma exchange in accelerating natalizumab clearance and restoring leukocyte function

scientific article published on February 2009

Effects of delayed-release dimethyl fumarate (DMF) on health-related quality of life in patients with relapsing-remitting multiple sclerosis: an integrated analysis of the phase 3 DEFINE and CONFIRM studies

scientific article published on 12 October 2014

Effects of delayed-release dimethyl fumarate on MRI measures in the Phase 3 DEFINE study

scientific article

Efficacy and Safety of Delayed-release Dimethyl Fumarate for Relapsing-remitting Multiple Sclerosis in Prior Interferon Users: An Integrated Analysis of DEFINE and CONFIRM.

scientific article

Efficacy and safety of delayed-release dimethyl fumarate in patients newly diagnosed with relapsing-remitting multiple sclerosis (RRMS).

scientific article

Efficacy of Cladribine Tablets in high disease activity subgroups of patients with relapsing multiple sclerosis: A post hoc analysis of the CLARITY study

scientific article published in April 2018

Elevated cerebrospinal fluid and serum nitrate and nitrite levels in patients with central nervous system complications of HIV-1 infection: a correlation with blood-brain-barrier dysfunction ⬇️

scientific article published on January 1, 1998

Emerging therapies in multiple sclerosis

scientific article published in November 2005

Environmental factors and their timing in adult-onset multiple sclerosis

scientific article published on 16 February 2010

Enzymatic degradation of RNA causes widespread protein aggregation in cell and tissue lysates

scientific article published on 18 September 2020

Epstein Barr virus shedding in multiple sclerosis: Similar frequencies of EBV in saliva across separate patient cohorts

scientific article published on 27 July 2018

Epstein-Barr-negative MS: a true phenomenon?

scientific article published on 03 February 2017

Epstein–Barr Virus and Multiple Sclerosis

Epstein–Barr virus and multiple sclerosis: association or causation? ⬇️

scientific article published on March 1, 2013

Epstein–Barr virus, latitude and multiple sclerosis ⬇️

scientific article published on July 5, 2012

Estimating the proportion of variation in susceptibility to multiple sclerosis captured by common SNPs ⬇️

scientific article published on October 25, 2012

Evaluation of no evidence of progression or active disease (NEPAD) in patients with primary progressive multiple sclerosis in the ORATORIO trial

Evidence for acute neurotoxicity after chemotherapy ⬇️

scientific article published on December 1, 2010

Fatigue is not associated with raised inflammatory markers in multiple sclerosis

scientific article published in August 2001

Fingolimod and CSF neurofilament light chain levels in relapsing-remitting multiple sclerosis

scientific article published on 25 March 2015

Fingolimod modulates microglial activation to augment markers of remyelination ⬇️

scientific article published on July 5, 2011

Gender identity disorders and multiple sclerosis risk: A national record-linkage study

scientific article published on 8 February 2016

Genetic background can result in a marked or minimal effect of gene knockout (GPR55 and CB2 receptor) in experimental autoimmune encephalomyelitis models of multiple sclerosis

scientific article

Genomic regions associated with multiple sclerosis are active in B cells

scientific article (publication date: 2012)

Geography of hospital admissions for multiple sclerosis in England and comparison with the geography of hospital admissions for infectious mononucleosis: a descriptive study ⬇️

scientific article published on January 6, 2011

Growth associated protein (GAP-43): cloning and the development of a sensitive ELISA for neurological disorders

scientific article published on 23 July 2014

Guidelines for uniform reporting of body fluid biomarker studies in neurologic disorders

scientific article published on 22 August 2014

Guidelines on routine cerebrospinal fluid analysis. Report from an EFNS task force

scientific article published on September 2006

Guthrie card methylomics identifies temporally stable epialleles that are present at birth in humans

scientific article

HIV and lower risk of multiple sclerosis: beginning to unravel a mystery using a record-linked database study

scientific article

HLA-DR15, low infant sibling exposure and MS: gene-environment interaction

article

HLA-DRB1 and month of birth in multiple sclerosis

article by S. V. Ramagopalan et al published 14 December 2009 in Neurology

Haptoglobins as markers of blood-CSF barrier dysfunction: the findings in normal CSF.

scientific article

Health-related quality of life in multiple sclerosis: effects of natalizumab

scientific article

Hospital admissions for vitamin D related conditions and subsequent immune-mediated disease: record-linkage studies ⬇️

scientific article published on July 25, 2013

How to refer to people with disease in research outputs: The disconnection between academic practise and that preferred by people with multiple sclerosis

scientific article published on 13 October 2016

How to start a blog

Start blog in simple steps in 2021

Human Endogenous Retroviruses in Neurological Diseases

scientific article published on 15 March 2018

Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI.

scientific article

Hypovitaminosis-D and EBV: no interdependence between two MS risk factors in a healthy young UK autumn cohort

scientific article published on 5 November 2013

Immune reactivity to neurofilament proteins in the clinical staging of amyotrophic lateral sclerosis

scientific article published on 27 September 2013

Immunological surrogate markers of disease activity in multiple sclerosis

scientific article

Immunopathogenesis and immunotherapeutic approaches in multiple sclerosis

scientific article

Immunopathogenic mechanisms in tourette syndrome: A critical review

scientific article

Immunosuppression with FTY720 is insufficient to prevent secondary progressive neurodegeneration in experimental autoimmune encephalomyelitis ⬇️

scientific article published on April 1, 2011

Incorporation of an interferon-β neutralizing antibody assay into routine clinical practice ⬇️

scientific article published on June 17, 2011

Increase of uric acid and purine compounds in biological fluids of multiple sclerosis patients

scientific article

Increased neurofilament light chain blood levels in neurodegenerative neurological diseases

scientific article

Increased urinary excretion of nitric oxide metabolites in longitudinally monitored migraine patients

scientific article

Increased urinary free immunoglobulin light chain excretion in patients with multiple sclerosis

scientific article published on 19 February 2010

Integrating multiple oestrogen receptor alpha ChIP studies: overlap with disease susceptibility regions, DNase I hypersensitivity peaks and gene expression

scientific article

Interferon beta in multiple sclerosis: experience in a British specialist multiple sclerosis centre

scientific article

Interpreting Lymphocyte Reconstitution Data From the Pivotal Phase 3 Trials of Alemtuzumab

scientific article

Is it time to target no evident disease activity (NEDA) in multiple sclerosis?

scientific article (publication date: July 2015)

Is the 'MS establishment' biased; the case for addressing gender inequality in the field of MS?

scientific article published on 20 December 2018

Konsensusprotokoll zur Standardisierung von Entnahme und Biobanking des Liquor cerebrospinalis 1 / A consensus protocol for the standardisation of cerebrospinal fluid collection and biobanking

Lack of serum oligoclonal antibody responses to Chlamydophila pneumoniae in multiple sclerosis

scientific article published on 05 April 2005

Learning ability correlates with brain atrophy and disability progression in RRMS

scientific article published on 15 October 2018

Learning from other autoimmunities to understand targeting of B cells to control multiple sclerosis

scientific article published on 01 October 2018

Lesional-targeting of neuroprotection to the inflammatory penumbra in experimental multiple sclerosis

scientific article published on 27 November 2013

Letter to the editor

Long term lymphocyte reconstitution after alemtuzumab treatment of multiple sclerosis

scientific article published on 5 November 2011

Long-term effects of cladribine tablets on MRI activity outcomes in patients with relapsing-remitting multiple sclerosis: the CLARITY Extension study

scientific article published on 23 January 2018

Long-term safety data from the cladribine tablets clinical development program in multiple sclerosis

scientific article published on 08 October 2020

Longitudinal study of soluble adhesion molecules in multiple sclerosis: correlation with gadolinium enhanced magnetic resonance imaging

scientific article published in June 1997

MRI outcomes in a placebo-controlled trial of natalizumab in relapsing MS.

scientific article

MRI outcomes with cladribine tablets for multiple sclerosis in the CLARITY study

scientific article

MSer - A new, neutral descriptor for someone with multiple sclerosis

scientific article published on 17 July 2013

Magnetization transfer ratio in the delayed-release dimethyl fumarate DEFINE study

scientific article

Marked neutropenia: Significant but rare in people with multiple sclerosis after alemtuzumab treatment

scientific article published on 25 September 2017

Markers for different glial cell responses in multiple sclerosis: clinical and pathological correlations

scientific article published in July 2002

Matrix metalloproteinases in inflammatory demyelination: targets for treatment

scientific article

Memory B Cells are Major Targets for Effective Immunotherapy in Relapsing Multiple Sclerosis

scientific article published on 31 January 2017

Meta-analysis of the relationship between multiple sclerosis and migraine

scientific article

Mifepristone or inhibition of 11beta-hydroxylase activity potentiates the sedating effects of the cannabinoid receptor-1 agonist Delta(9)-tetrahydrocannabinol in mice

scientific article published in May 2003

More to come: humoral immune responses in MS.

scientific article published on 21 October 2011

Multiple Sclerosis - a review

article

Multiple sclerosis and its treatment

scientific article

Multiple sclerosis in the Iranian immigrant population of BC, Canada: prevalence and risk factors

scientific article published on 10 January 2014

Multiple sclerosis outpatient future groups: improving the quality of participant interaction and ideation tools within service improvement activities

scientific article published on 23 April 2015

Multiple sclerosis therapy and Epstein-Barr virus antibody titres

scientific article

Multiple sclerosis, lymphoma and nasopharyngeal carcinoma: the central role of Epstein-Barr virus?

scientific article published on 25 November 2009

Multiple sclerosis: Neurofilament light chain antibodies are correlated to cerebral atrophy

scientific article published in January 2003

Multiple sclerosis: a practical overview for clinicians

scientific article published on 04 July 2010

Multiple sclerosis: risk factors, prodromes, and potential causal pathways

scientific article published on July 2010

Natalizumab reduces visual loss in patients with relapsing multiple sclerosis

scientific article

Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases

scientific article published on April 2010

National survey of UK medical students on the perception of neurology

scientific article

Neural cell adhesion molecule--description of a CSF ELISA method and evidence of reduced levels in selected neurological disorders

scientific article

Neural cell adhesion molecules in brain plasticity and disease

scientific article published on 25 September 2012

Neurofilament ELISA validation

scientific article published on 24 October 2009

Neurofilament a biomarker of neurodegeneration in autoimmune encephalomyelitis ⬇️

scientific article published on February 15, 2012

Neurofilament light and heavy subunits compared as therapeutic biomarkers in multiple sclerosis

scientific article published on 13 June 2013

Neurofilament light chain: A prognostic biomarker in amyotrophic lateral sclerosis.

scientific article published on May 2015

Neuroprotection in Experimental Autoimmune Encephalomyelitis and Progressive Multiple Sclerosis by Cannabis-Based Cannabinoids

scientific article published on 24 December 2014

Neuroprotection in a novel mouse model of multiple sclerosis

scientific article (publication date: 2013)

Neuropsychiatric-developmental model for the expression of tics, pervasive developmental disorder, and schizophreniform symptomatology associated with PANDAS.

scientific article published in January 2009

Neutralising antibodies to interferon beta during the treatment of multiple sclerosis

scientific article

Neutralising antibodies to interferon beta in multiple sclerosis : expert panel report

scientific article published on 24 April 2007

No evidence of disease activity (NEDA) analysis by epochs in patients with relapsing multiple sclerosis treated with ocrelizumab vs interferon beta-1a

scientific article published in January 2018

No evidence of disease activity in patients receiving daclizumab versus intramuscular interferon beta-1a for relapsing-remitting multiple sclerosis in the DECIDE study

scientific article published in December 2016

No evidence of disease activity: indirect comparisons of oral therapies for the treatment of relapsing-remitting multiple sclerosis

scientific article

No laughing matter: subacute degeneration of the spinal cord due to nitrous oxide inhalation.

scientific article

Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis

scientific article published on 21 December 2016

Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis

scientific article published on 21 December 2016

Parkinson's disease determinants, prediction and gene-environment interactions in the UK Biobank

scientific article published on 01 October 2020

Pediatric multiple sclerosis: Escalation and emerging treatments

scientific article

Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis ⬇️

scientific article published on September 20, 2012

Plasma cell and B cell-targeted treatments for use in advanced multiple sclerosis

scientific article published on 26 June 2019

Plasma neurofilament heavy chain levels and disease progression in amyotrophic lateral sclerosis: insights from a longitudinal study

scientific article published on 9 July 2014

Post-streptococcal autoimmune neuropsychiatric disease presenting as paroxysmal dystonic choreoathetosis

scientific article

Poststreptococcal acute disseminated encephalomyelitis with basal ganglia involvement and auto‐reactive antibasal ganglia antibodies ⬇️

scientific article published on November 1, 2001

Practical guide to the induction of relapsing progressive experimental autoimmune encephalomyelitis in the Biozzi ABH mouse

scientific article

Pretreatment of astrocytes with interferon-alpha/beta impairs interferon-gamma induction of nitric oxide synthase.

scientific article published in June 1997

Prevalence and demographics of multiple sclerosis-associated uveitis: a UK biobank study

scientific article published on 23 May 2020

Prevalence of MS in Iranian Immigrants to British Columbia, Canada

article

Prevalence of anti-basal ganglia antibodies in adult obsessive-compulsive disorder: cross-sectional study

scientific article published on 26 January 2012

Progression in multiple sclerosis is associated with low endogenous NCAM ⬇️

scientific article published on April 19, 2013

Protease-activated receptor-1 activation by granzyme B causes neurotoxicity that is augmented by interleukin-1β

scientific article

Protecting people with multiple sclerosis through vaccination

scientific article published on 06 July 2020

Psychiatric disorders in children with demyelinating diseases of the central nervous system

scientific article

Quality of life outcomes with BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: the DEFINE study

scientific article

Quantification of neurodegeneration by measurement of brain-specific proteins ⬇️

scientific article published on May 1, 2003

RECRUITMENT IN MULTIPLE SCLEROSIS TRIALS: THE MS-SMART EXPERIENCE ⬇️

Recommendations for clinical use of data on neutralising antibodies to interferon-beta therapy in multiple sclerosis

scientific article

Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement

scientific article

Reduced brain atrophy rates are associated with lower risk of disability progression in patients with relapsing multiple sclerosis treated with cladribine tablets

scientific article published in January 2017

Reduction in Healthcare and Societal Resource Utilization Associated with Cladribine Tablets in Patients with Relapsing-Remitting Multiple Sclerosis : Analysis of Economic Data from the CLARITY Study

scientific article

Relapses Requiring Intravenous Steroid Use and Multiple-Sclerosis-related Hospitalizations: Integrated Analysis of the Delayed-release Dimethyl Fumarate Phase III Studies

scientific article published on 30 October 2015

Relationship of UV exposure to prevalence of multiple sclerosis in England ⬇️

scientific article published on April 19, 2011

Risk stratification for progressive multifocal leukoencephalopathy in patients treated with natalizumab

scientific article published on February 2012

Réduction à long-terme du taux de poussées et de progression du handicap après 6 ans de traitement par ocrelizumab (OCR) chez des patients atteints de sclérose en plaques récurrente (SEP-R)

scientific article published on 01 September 2020

Safety and efficacy of cladribine tablets in patients with relapsing-remitting multiple sclerosis: Results from the randomized extension trial of the CLARITY study

scientific article published in August 2017

Safety and tolerability of cladribine tablets in multiple sclerosis: the CLARITY (CLAdRIbine Tablets treating multiple sclerosis orallY) study

Safety and tolerability profile of daclizumab in patients with relapsing-remitting multiple sclerosis: An integrated analysis of clinical studies

scientific article published on 11 May 2016

Safety of cladribine tablets in the treatment of patients with multiple sclerosis: An integrated analysis

scientific article published on 20 November 2018

Science is 1% inspiration and 99% biomarkers

scientific article published in May 2017

Seroprevalence of herpes simplex virus type 2 in multiple sclerosis

scientific article published in December 2006

Serum S100B in primary progressive multiple sclerosis patients treated with interferon-beta-1a

scientific article

Serum and urine nitrate and nitrite are not reliable indicators of intrathecal nitric oxide production in acute brain injury

scientific article published in April 2003

Serum gelatinase B/MMP-9 in primary progressive multiple sclerosis patients treated with interferon-beta-1a

scientific article

Serum inflammatory markers and clinical/MRI markers of disease progression in multiple sclerosis

scientific article

Serum neurofilament is associated with progression of brain atrophy and disability in early MS.

scientific article published on February 2017

Serum neurofilament light chain is a biomarker of human spinal cord injury severity and outcome

scientific article published on 16 June 2014

Serum neurofilament light chain levels are increased in patients with a clinically isolated syndrome

scientific article published on 25 February 2015

Sex ratio of infectious mononucleosis and possible relevance to multiple sclerosis ⬇️

scientific article published on July 10, 2012

Simvastatin in patients with progressive multiple sclerosis

scientific article

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

scientific article published on 22 March 2018

Smoking and multiple sclerosis: an updated meta-analysis

scientific article

Soluble E-selectin in multiple sclerosis: raised concentrations in patients with primary progressive disease

scientific article published on January 1996

Soluble adhesion molecules in Gilles de la Tourette's syndrome

scientific article published on July 2005

Soluble adhesion molecules in acute disseminated encephalomyelitis

scientific article published in October 2005

Sphingosine 1-phosphate Receptor Modulator Therapy for Multiple Sclerosis: Differential Downstream Receptor Signalling and Clinical Profile Effects

scientific article published on 08 December 2020

Superior MRI outcomes with alemtuzumab compared with subcutaneous interferon β-1a in MS.

scientific article published on 02 September 2016

Survey of diagnostic and treatment practices for multiple sclerosis in Europe, part 2: progressive MS, paediatric MS, pregnancy and general management

scientific article published on 21 January 2018

Sustained Effect of Delayed-Release Dimethyl Fumarate in Newly Diagnosed Patients with Relapsing-Remitting Multiple Sclerosis: 6-Year Interim Results From an Extension of the DEFINE and CONFIRM Studies

scientific article published on March 2016

Sustained disease-activity-free status in patients with relapsing-remitting multiple sclerosis treated with cladribine tablets in the CLARITY study: a post-hoc and subgroup analysis

scientific article published in April 2011

Switching from natalizumab to fingolimod: A randomized, placebo-controlled study in RRMS

scientific article published on 29 May 2015

Switching patients at high risk of PML from natalizumab to another disease-modifying therapy

scientific article

Systematic approach to selecting licensed drugs for repurposing in the treatment of progressive multiple sclerosis

scientific article published on 12 November 2020

Systematic review of disease-modifying therapies to assess unmet needs in multiple sclerosis: tolerability and adherence ⬇️

scientific article published on January 16, 2012

THE MS-SMART TRIAL IN SECONDARY PROGRESSIVE MS – CURRENT UPDATE ⬇️

Tackling comorbidity in multiple sclerosis

scientific article published on 13 July 2017

Testicular hypofunction and multiple sclerosis risk: a record-linkage study

scientific article published on 30 August 2014

The BRAIN test: a keyboard-tapping test to assess disability and clinical features of multiple sclerosis

scientific article published on 4 December 2017

The McDonald Criteria for Multiple Sclerosis: time for clarification

scientific article published in March 2010

The PANDAS subgroup of tic disorders and childhood-onset obsessive-compulsive disorder

scientific article

The biology that underpins the therapeutic potential of cannabis-based medicines for the control of spasticity in multiple sclerosis

scientific article published on 18 January 2012

The clinical significance of an intrathecal monoclonal immunoglobulin band: a follow-up study

scientific article published in April 2003

The diagnostic criteria for multiple sclerosis: From Charcot to McDonald

scientific article

The effect of gender in clinically isolated syndrome (CIS): a meta-analysis ⬇️

scientific article published on October 12, 2011

The effect of vitamin D-related interventions on multiple sclerosis relapses: a meta-analysis ⬇️

scientific article published on May 22, 2013

The effects of intrathecal rituximab on biomarkers in multiple sclerosis

scientific article published on 19 January 2016

The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL

scientific article published on 29 May 2009

The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL.

scientific article published on 18 March 2009

The evidence for a role of B cells in multiple sclerosis ⬇️

scientific article published on March 13, 2012

The immunopathogenesis of multiple sclerosis and Guillain-Barré syndrome.

scientific article published on June 1996

The impact of social capital on patients with multiple sclerosis

scientific article published on 18 March 2020

The implications of immunogenicity for protein-based multiple sclerosis therapies

scientific article published on 25 September 2008

The importance of a multi-disciplinary perspective and patient activation programmes in MS management

scientific article

The incidence and significance of anti-natalizumab antibodies: results from AFFIRM and SENTINEL.

scientific article

The month of birth effect in multiple sclerosis: systematic review, meta-analysis and effect of latitude ⬇️

scientific article published on November 14, 2012

The potential role of nitric oxide in multiple sclerosis ⬇️

scientific article published on June 1, 1998

The refinement of genetic predictors of multiple sclerosis

scientific article

The risk of developing multiple sclerosis in individuals seronegative for Epstein-Barr virus: a meta-analysis

scientific article published on June 11, 2012

The role of antibody affinity for specific antigens in the differential diagnosis of inflammatory nervous system disorders

scientific article published on 23 August 2006

The role of infections in Behçet disease and neuro-Behçet syndrome

scientific article published on 11 March 2015

The therapeutic potential of cannabis

scientific article

Therapies for multiple sclerosis: considerations in the pediatric patient

scientific article published on 11 January 2011

Time course of clinical and neuroradiological effects of delayed-release dimethyl fumarate in multiple sclerosis

scientific article

Time- and Region-Specific Season of Birth Effects in Multiple Sclerosis in the United Kingdom

scientific article published on 27 June 2016

Tourette's syndrome: a cross sectional study to examine the PANDAS hypothesis

scientific article

Towards a global view of multiple sclerosis genetics

scientific article published on 8 September 2022

Translational Mini-Review Series on B cell subsets in disease. B cells in multiple sclerosis: drivers of disease pathogenesis and Trojan horse for Epstein-Barr virus entry to the central nervous system?

scientific article published on January 2012

Treatment response in relation to inflammatory and axonal surrogate marker in multiple sclerosis

scientific article published in June 2004

UK consensus on pregnancy in multiple sclerosis: 'Association of British Neurologists' guidelines

scientific article published on 05 January 2019

Unihemispheric cerebral vasculitis mimicking Rasmussen's encephalitis.

scientific article

Unmet needs, burden of treatment, and patient engagement in multiple sclerosis: A combined perspective from the MS in the 21st Century Steering Group

scientific article published on 21 November 2017

Urinary neopterin and nitric oxide metabolites as markers of interferon beta-1a activity in primary progressive multiple sclerosis

scientific article published on 16 July 2010

Use of Magnetic Resonance Imaging as Well as Clinical Disease Activity in the Clinical Classification of Multiple Sclerosis and Assessment of Its Course: A Report from an International CMSC Consensus Conference, March 5-7, 2010

scientific article published on January 2012

Validating a novel web-based method to capture disease progression outcomes in multiple sclerosis ⬇️

scientific article published on June 27, 2013

Validating parameters of a luciferase reporter gene assay to measure neutralizing antibodies to IFNbeta in multiple sclerosis patients

scientific article

Validation of an environmentally-friendly and affordable cardboard 9-hole peg test

scientific article published on 9 August 2017

Varicella-zoster virus encephalitis mimicking toxoplasmosis relapse

scientific article

Viral pathophysiology of multiple sclerosis: A role for Epstein-Barr virus infection?

scientific article published on 09 June 2010

Visibility and representation of women in multiple sclerosis research.

scientific article published on 20 March 2019

Vitamin D supplementation and antibodies against the Epstein-Barr virus in multiple sclerosis patients

scientific article

Vitamin D supplementation.

scientific article

Vitamin D: a link between Epstein–Barr virus and multiple sclerosis development? ⬇️

scientific article published on September 1, 2011

Vitamin D–Dependent Rickets, HLA-DRB1, and the Risk of Multiple Sclerosis

e-Health and multiple sclerosis: An update

article published in 2018

e-Health and multiple sclerosis: An update

scientific article published on 19 September 2018

Paulina is supported by:

About Paulina

Help